AusBiotech congratulates the founders of medtech company SpeeDx for winning the coveted Clunies Ross Award for Innovation, in recognition of their dedication to fostering entrepreneurship and innovation in Australia.
Doctors Alison Todd, valued AusBiotech NSW State Branch Committee member, and Elisa Mokany founded SpeeDx. The Australian Academy of Technology and Engineering (ATSE) says, “[The company was founded] to roll out the technology which helps doctors choose personally targeted treatments. Together, Dr Todd and Dr Mokany created a new molecular ‘lego’ that is opening the door to personalised clinical diagnostics.
“They combine a profound, deep knowledge of molecular DNA and RNA-based detection – with flair and entrepreneurship, to develop their own inventions into fully-fledged products made in Australia and sold nationally and around the world. Their products are fundamentally changing the way in which doctors work and patients heal.”
Lorraine Chiroiu, CEO, AusBiotech, says, “AusBiotech is delighted that home-grown, world-leading talent continues to be recognised. Congratulations to Alison and Elisa, for your inspiring contribution to science, industry, and to patients.”
The Clunies Ross Awards have a proud 28-year tradition of recognising contributions by dedicated individuals who have shared their vision and knowledge with others to apply technology for the benefit of Australia. The Awards are administered by the Australian Academy of Technology and Engineering.